Month: January 2022

Thus, we demonstrated recently, after in vivo transplantation of L428 cells in different phases of antigen acquisition, how the design of TMMs evolves, with high telomerase expression in the tiny CD30?/CD15? cells, and intensifying expression of the ALT profile until acquisition of the HRS cell phenotype, with predominant PML physiques, low telomerase manifestation [56], and the current presence of tumor cells without TMM staining

Thus, we demonstrated recently, after in vivo transplantation of L428 cells in different phases of antigen acquisition, how the design of TMMs evolves, with high […]

Continue reading